Therapeutic plasma exchange in hypertriglyceridemic patients
- PMID: 31203594
- PMCID: PMC7018319
- DOI: 10.3906/sag-1811-105
Therapeutic plasma exchange in hypertriglyceridemic patients
Abstract
Background/aim: High triglyceride (TG) levels are associated with increases in atherosclerotic cardiovascular disease (CVD), hepatic steatosis, and pancreatitis. Acute pancreatitis is a condition with high mortality. Therapeutic plasma exchange (TPE) in the treatment of hypertriglyceridemic pancreatitis (HTGP) is a rapid and effective treatment modality. In this study, the results of TPE were evaluated and the frequency of lipoprotein lipase (LPL) mutation in these patients was determined.
Materials and methods: TPE was performed in 31 patients with HTGP at the Adult Therapeutic Apheresis Center.
Results: A TG level under 500 mg/dL was achieved by applying apheresis at a median of 2 times (IQR 2–2, min 1, max 6) in the 31 cases. LPL mutation was detected in 8 (25.8%) of the 31 hypertriglyceridemia cases. When TG levels before and after TPE were evaluated, the mean TG level before TPE was significantly higher (3132 ± 1472 mg/dL) than the mean TG level afterwards (948 ± 465 mg/dL, P < 0.001). This result represented a decrease of 69.7% TG after TPE.
Conclusion: TPE is a safe, fast, and effective treatment modality in experienced centers.
Keywords: Hypertriglyceridemia; pancreatitis; apheresis; therapeutic plasma exchange; fresh frozen plasma.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Conflict of interest statement
none declared
References
-
- Durrington P. Dyslipidaemia Lancet. 2003;363:717. - PubMed
-
- Fortson MR Freedman SN Webster PD Clinical assessment of hyperlipidemic pancreatitis. American Journal of Gastroenterology. 1995;90:2134. - PubMed
-
- Chang CC Hsieh YY Tsai HD Yang TC Yeh LS Acute pancreatitis in pregnancy. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61:85. - PubMed
-
- Ewald N Hardt PD Kloer HU Severe hypertriglyceridemia and pancreatitis: presentation and management. Current Opinion in Lipidology. 2009;20:497. - PubMed
-
- Nordestgaard BG Langsted A Mora S Kolovou G Baum H Fasting is not routinely required for determination of a lipid profile. Clinical and laboratory implications including flagging at desirable concentration cutpoints- A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry. 2016;62:930. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
